John P. Butler

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Carolyn M. Rucci, attorney-in-fact for John P. Butler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John P. Butler:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. CEO and President, Director Common Stock 3,297,794 $4,583,933 $1.39 02 Feb 2026 Direct
Akebia Therapeutics, Inc. CEO and President, Director Common Stock 159,928 $257,484 $1.61 02 Feb 2026 Held by Dorothy Butler Revocable Trust November 20, 2007
Akebia Therapeutics, Inc. CEO and President, Director Stock Option (Right to buy) 1,115,000 30 Jan 2026 Direct
Akebia Therapeutics, Inc. CEO and President, Director Performance Stock Units 350,500 31 Jan 2025 Direct
Zynerba Pharmaceuticals, Inc. Director Common Stock 0 $1.33 10 Oct 2023 Direct
Zynerba Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 10 Oct 2023 Direct

Insider Reports Filed by John P. Butler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 02 Feb 2026 5 -$227,311 4 CEO and President, Director 04 Feb 2026, 16:10
AKBA Akebia Therapeutics, Inc. 30 Jan 2026 2 $0 4 CEO and President, Director 03 Feb 2026, 16:35
AKBA Akebia Therapeutics, Inc. 03 Mar 2025 1 -$84,928 4 CEO and President, Director 04 Mar 2025, 17:05
AKBA Akebia Therapeutics, Inc. 31 Jan 2025 5 -$302,925 4 CEO and President, Director 04 Feb 2025, 17:54
AKBA Akebia Therapeutics, Inc. 29 Feb 2024 1 -$73,581 4 CEO and President, Director 01 Mar 2024, 17:47
AKBA Akebia Therapeutics, Inc. 27 Feb 2024 1 -$57,354 4 CEO and President, Director 29 Feb 2024, 18:00
AKBA Akebia Therapeutics, Inc. 31 Jan 2024 3 -$78,102 4 CEO and President, Director 02 Feb 2024, 16:10
/report/000114036123047727-butler-john-p-2023-10-10 Zynerba Pharmaceuticals, Inc. 10 Oct 2023 4 $0 4 Director 11 Oct 2023, 09:58
/report/000106299323013664-butler-john-p-2023-06-13 Zynerba Pharmaceuticals, Inc. 13 Jun 2023 3 -$40.03 4 Director 15 Jun 2023, 16:28
AKBA Akebia Therapeutics, Inc. 01 Mar 2023 3 -$80,614 4 CEO and President, Director 03 Mar 2023, 07:01
AKBA Akebia Therapeutics, Inc. 27 Feb 2023 1 -$31,416 4 CEO and President, Director 01 Mar 2023, 15:07
AKBA Akebia Therapeutics, Inc. 31 Jan 2023 3 $0 4 CEO and President, Director 02 Feb 2023, 15:15
/report/000106299322015037-butler-john-p-2022-06-14 Zynerba Pharmaceuticals, Inc. 14 Jun 2022 3 -$53.53 4 Director 16 Jun 2022, 21:48
AKBA Akebia Therapeutics, Inc. 28 Feb 2022 6 -$171,143 4 CEO and President, Director 02 Mar 2022, 20:25
/report/000119248221000646-butler-john-p-2021-08-03 Zynerba Pharmaceuticals, Inc. 03 Aug 2021 2 $0 4 Director 05 Aug 2021, 17:28
AKBA Akebia Therapeutics, Inc. 12 Dec 2018 1 $0 4/A CEO and President, Director 18 Feb 2022, 20:55